GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » EV-to-EBIT

Medipal Holdings (TSE:7459) EV-to-EBIT

: 4.70 (As of Today)
View and export this data going back to 1995. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medipal Holdings's Enterprise Value is 円315,731 Mil. Medipal Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円67,133 Mil. Therefore, Medipal Holdings's EV-to-EBIT for today is 4.70.

The historical rank and industry rank for Medipal Holdings's EV-to-EBIT or its related term are showing as below:

TSE:7459' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.08   Med: 6.35   Max: 9.94
Current: 4.7

During the past 13 years, the highest EV-to-EBIT of Medipal Holdings was 9.94. The lowest was 4.08. And the median was 6.35.

TSE:7459's EV-to-EBIT is ranked better than
86.42% of 81 companies
in the Medical Distribution industry
Industry Median: 13.36 vs TSE:7459: 4.70

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medipal Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was 円397,957 Mil. Medipal Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円67,133 Mil. Medipal Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 16.87%.


Medipal Holdings EV-to-EBIT Historical Data

The historical data trend for Medipal Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.73 4.48 7.12 5.41 4.43

Medipal Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.34 4.43 5.90 6.58 5.93

Competitive Comparison

For the Medical Distribution subindustry, Medipal Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipal Holdings EV-to-EBIT Distribution

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's EV-to-EBIT falls into.



Medipal Holdings EV-to-EBIT Calculation

Medipal Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=315731.071/67133
=4.70

Medipal Holdings's current Enterprise Value is 円315,731 Mil.
Medipal Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円67,133 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipal Holdings  (TSE:7459) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medipal Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=67133/397956.8535
=16.87 %

Medipal Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was 円397,957 Mil.
Medipal Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円67,133 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipal Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipal Holdings (TSE:7459) Business Description

Traded in Other Exchanges
Address
2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines